Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly
Authors:
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The potential economic value of a ‘universal’ (multi‐year) influenza vaccineInfluenza and Other Respiratory Viruses, 2011
- Complications and Outcomes of Pandemic 2009 Influenza A (H1N1) Virus Infection in Hospitalized Adults: How Do They Differ From Those in Seasonal Influenza?The Journal of Infectious Diseases, 2011
- Efficacy Studies of Influenza Vaccines: Effect of End Points Used and Characteristics of Vaccine FailuresThe Journal of Infectious Diseases, 2011
- Differences in the Epidemiological Characteristics and Clinical Outcomes of Pandemic (H1N1) 2009 Influenza, Compared with Seasonal InfluenzaInfection Control & Hospital Epidemiology, 2010
- To Test or to Treat? An Analysis of Influenza Testing and Antiviral Treatment Strategies Using Economic Computer ModelingPLOS ONE, 2010
- Outcomes of adults hospitalised with severe influenzaThorax, 2010
- The timing of influenza vaccination for older adults (65 years and older)Vaccine, 2009
- Antiviral Therapy and Outcomes of Influenza Requiring Hospitalization in Ontario, CanadaClinical Infectious Diseases, 2007
- Toward Consistency in Cost-Utility AnalysesMedical Care, 1998
- Community Pharmacists as Immunization AdvocatesMedical Care, 1992